Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes? - Wikidata - wikimedia - TriplyDB

Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

http://www.wikidata.org/entity/Q37110513

about

Does losartan prevent progression of early diabetic nephropathy in American Indians with type 2 diabetes?

http://www.wikidata.org/entity/Q37110513

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Does losartan prevent progress ...... Indians with type 2 diabetes?

@en

Does losartan prevent progress ...... Indians with type 2 diabetes?

@nl

type

label

Does losartan prevent progress ...... Indians with type 2 diabetes?

@en

Does losartan prevent progress ...... Indians with type 2 diabetes?

@nl

prefLabel

Does losartan prevent progress ...... Indians with type 2 diabetes?

@en

Does losartan prevent progress ...... Indians with type 2 diabetes?

@nl

P1433

Q37110513-AB32502A-B288-4852-893A-8636A42DAE1F

P1476

Q37110513-421D593C-40CC-4975-B049-EEC394363ACA

P2093

Q37110513-5D18E2BB-4B3A-4E52-8A27-AC406074B17A

P2860

Q37110513-0559A8A6-F1BC-4A59-BAA1-9F859246E124

Q37110513-16FBB938-1722-4A31-81D5-498C511F0EE0

Q37110513-20B94A77-3D47-4FD7-AF42-CC8FE1FDE7D0

Q37110513-253AD9C3-464C-44FF-9BC9-E70B1B285196

Q37110513-373B68B2-4C73-472E-9DD8-89AA367AAD24

Q37110513-3BED5665-2F24-43F5-BF33-0CBB1CD62CCE

Q37110513-3CCE263A-F609-4FA3-BE05-A9CD8B9FC2A7

Q37110513-47CFB27B-82C4-4FAA-B66A-EF3154373EFA

Q37110513-5CB059CE-439C-4A67-9E57-BFC4F4C20A3A

Q37110513-66E3BE61-9F48-4A87-A51C-CF811D02BD69

P304

Q37110513-5F14F743-C86B-4C0C-BB5A-1DAB9E2DF993

P31

Q37110513-AD3AACFD-020A-4EB1-9C6F-70555897AC9A

P356

Q37110513-52A629FA-BD75-43D3-B30E-E631A01AF92F

P407

Q37110513-40D87734-0589-43BB-8317-807AFDCEDB6E

P433

Q37110513-007F755F-AFB7-401B-984C-1A470A78DA55

P478

Q37110513-411079A3-0DAD-45B0-A73D-2EC318B1BEB2

P50

Q37110513-591E9D2A-FEB8-498F-9C71-09CAB6F20086

P577

Q37110513-AD3537A2-37CA-4C4F-A25D-4339A5609A4A

P5875

Q37110513-33E27688-6103-4FE6-9CE6-AF12E0AF1A03

P698

Q37110513-CB6A036C-8A8C-494A-A647-BD74D4EFDF84

P921

Q37110513-C01845ED-D3C1-40E9-9560-BB038A0C6B8B

P932

Q37110513-E268B546-AFF4-48F5-93D2-BFFC3BA784A7

P356

P1433

P1476

Does losartan prevent progress ...... Indians with type 2 diabetes?

@en

P2093

Susanne B Nicholas

http://www.w3.org/2001/XMLSchema#string

P2860

Renal and retinal effects of enalapril and losartan in type 1 diabetes

Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study.

initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial.

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death

Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.

Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.

Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians.

Kidney disease and increased mortality risk in type 2 diabetes

Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes.

Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.

P304

3014-3016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB13-0748

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271055668

http://www.w3.org/2001/XMLSchema#string

P698

23970520

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3749328

http://www.w3.org/2001/XMLSchema#string